Herbert Virgin - 08 Feb 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
EVP, Research & CSO
Signature
/s/ Howard Horn, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
08 Feb 2022
Transactions value $
-$44,564
Form type
4
Filing time
09 Feb 2022, 17:58:43 UTC
Previous filing
26 Jan 2022
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Options Exercise $2.1K +1.38K +1.28% $1.53* 109K 08 Feb 2022 Direct
transaction VIR Common Stock Sale -$46.7K -1.38K -1.26% $33.94 108K 08 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Options Exercise $0 -1.38K -0.62% $0.00 221K 08 Feb 2022 Common Stock 1.38K $1.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021.
F2 The option is fully vested and exercisable.